Structural Mimicry of O-Antigen by a Peptide Revealed in a Complex with an Antibody Raised against Shigella flexneri Serotype 2a

Journal of Molecular Biology

Volumn 388, Issue 4, 2009, Pages 839-850

  Theillet, François Xavier ^a   Saul, Frederick A ^a   Vulliez Le Normand, Brigitte ^a   Hoos, Sylviane ^a   Felici, Franco ^b   Weintraub, Andrej ^c   Mulard, Laurence A ^a   Phalipon, Armelle ^d,e   Delepierre, Muriel ^a   Bentley, Graham A ^a  

^a CNRS   (France)

^b UNIVERSITY OF MOLISE   (Italy)

^c KAROLINSKA INSTITUTE   (Sweden)

^d INSTITUT PASTEUR   (France)

^e INSERM   (France)

Author keywords

antibody complex; carbohydrate peptide mimicry; crystal structure; shigellosis; solution NMR structure

Indexed keywords

O ANTIGEN;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN STRUCTURE; ARTICLE; BINDING AFFINITY; BINDING SITE; HYDROGEN BOND; MOLECULAR MIMICRY; NUCLEAR MAGNETIC RESONANCE; PHAGE DISPLAY; PRIORITY JOURNAL; SHIGELLA FLEXNERI; SHIGELLOSIS; THERMODYNAMICS;

SHIGELLA FLEXNERI 2A;

EID: 67349245215     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2009.03.057     Document Type: Article

References (46)

1. Jones C. Vaccines based on the cell surface carbohydrates of pathogenic bacteria. An. Acad. Bras. Cienc. 77 (2005) 293-324
2. Weintraub A. Immunology of bacterial polysaccharide antigens. Carb. Res. 338 (2003) 2539-2547
3. Johnson M.A., and Pinto B.M. Molecular mimicry of carbohydrates by peptides. Aust. J. Chem. 55 (2002) 13-25
4. Monzavi-Karbassi B., Cunto-Amesty G., Luo P., and Kieber-Emmons T. Peptide mimotopes as surrogate antigens of carbohydrates in vaccine discovery. Trends Biotechnol. 20 (2002) 207-214
5. Clement M.J., Fortune A., Phalipon A., Marcel-Peyre V., Simenel C., Imberty A., et al. Toward a better understanding of the bases of the molecular mimicry of polysaccharide antigens by peptides. The example of Shigella flexneri 5a. J. Biol. Chem. 281 (2006) 2317-2332
6. Lo Passo C., Romeo A., Pernice I., Donato P., Midiri A., Mancuso G., et al. Peptide mimics of the group B meningococcal capsule induce bactericidal and protective antibodies after immunization. J. Immunol. 178 (2007) 4417-4423
7. Buchwald U.K., Lees A., Steinitz M., and Pirofski L.A. A peptide mimotope of type 8 pneumococcal capsular polysaccharide induces a protective immune response in mice. Infect. Immun. 73 (2005) 325-333
8. Levine M.M., Kotloff K.L., Barry E.M., Pasetti M.F., and Sztein M.B. Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road. Nat. Rev. Microbiol. 5 (2007) 540-553
9. Jennison A.V., and Verma N.K. Shigella flexneri infection: pathogenesis and vaccine development. FEMS Microb. Rev. 28 (2004) 43-58
10. Kotloff K.L., Winickoff J.P., Ivanoff B., Clemens J.D., Swerdlow D.L., Sansonetti P.J., et al. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull. World Health Organ. 77 (1999) 651-666
11. Lindberg A.A., Karnell A., and Weintraub A. The lipopolysaccharide of Shigella bacteria as a virulence factor. Rev. Infect. Dis. 13 (1991) S279-S824
12. Kubler-Kielb J., Vinogradov E., Chu C., and Schneerson R. O-Acetylation in the O-specific polysaccharide isolated from Shigella flexneri 2a. Carbohydr. Res. 342 (2007) 643-647
13. Phalipon A., Costachel C., Grandjean C., Thuizat A., Guerreiro C., Tanguy M., et al. Characterization of functional oligosaccharide mimics of the Shigella flexneri serotype 2a O-antigen: implications for the development of a chemically defined glycoconjugate vaccine. J. Immunol. 176 (2006) 1686-1694
14. Vulliez-Le Normand B., Saul F.A., Phalipon A., Belot F., Guerreiro C., Mulard L.A., and Bentley A. Structures of synthetic O-antigen fragments from serotype 2a Shigella flexneri in complex with a protective monoclonal antibody. Proc. Natl Acad. Sci. USA 105 (2008) 9976-9981
15. Belot F., Guerreiro C., Baleux F., and Mulard L.A. Synthesis of two linear PADRE conjugates bearing a deca- or pentadecasaccharide B epitope as potential synthetic vaccines against Shigella flexneri serotype 2a infection. Chemistry 11 (2005) 1625-1694
16. Phalipon A., Tanguy M., Grandjean C., Guerreiro C., Belot F., Cohen D., et al. A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection. J. Immunol. 182 (2009) 2241-2247
17. Vyas N.K., Vyas M.N., Chervenak M.C., Bundle D.R., Pinto B.M., and Quiocho F.A. Structural basis of peptide-carbohydrate mimicry in an antibody-combining site. Proc. Natl Acad. Sci. USA 100 (2003) 15023-15028
18. Menendez A., Calarese D.A., Stanfield R.L., Chow K.C., Scanlan C.N., Kunert R., et al. A peptide inhibitor of HIV-1 neutralizing antibody 2G12 is not a structural mimic of the natural carbohydrate epitope on gp120. FASEB J. 22 (2008) 1380-1392
19. Nilges M., Macias M.J., O'Donoghue S.I., and Oschkinat H. Automated NOESY interpretation with ambiguous distance restraints: the refined NMR solution structure of the Pleckstrin homology domain from beta-spectrin. J. Mol. Biol. 269 (1997) 408-422
20. Laskowski R.A., Rullmannn J.A., MacArthur M.W., Kaptein R., and Thornton J.M. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR 8 (1996) 477-486
21. Lovell S.C., Davis I.W., Arendall III W.B., de Bakker P.I.W., Word J.M., Prisant M.G., et al. Structure validation by C alpha geometry: phi, psi and C beta deviation. Proteins 50 (2003) 437-450
22. Lawrence M.C., and Colman P.M. Shape complementarity at protein/protein interfaces. J. Mol. Biol. 234 (1993) 946-950
23. Kabat E.A., Wu T.T., Perry H.M., Gottesman K.S., and Foeller C. Sequences of Proteins of Immunological Interest. 5th edit (1991), US Department of Health and Human Services, NIH, Bethesda, MD
24. Yan J., Kline A.D., Mo H., Shapiro M.J., and Zartler E.R. The effect of relaxation on the epitope mapping by saturation transfer difference NMR. J. Magn. Res. 163 (2003) 270-276
25. Phalipon A., Folgori A., Arondel J., Sgaramella G., Fortugno P., Cortese R., et al. Induction of anti-carbohydrate antibodies by phage library selected peptide mimics. Eur. J. Immunol. 27 (1997) 2620-2625
26. Borrelli S., Hossany R.B., and Pinto B.M. Immunological evidence for functional rather than structural mimicry by Shigella flexneri Y polysaccharide-mimetic peptide. Clin. Vaccine Immunol. 15 (2008) 1106-1114
27. Beenhouwer D.O., May R.J., Valadon P., and Scharff M.D. High affinity mimotope of the polysaccharide capsule of Cryptococcus neoformans identified from an evolutionary phage peptide library. J. Immunol. 169 (2002) 6992-6999
28. Vargas-Madrazo E., Lara-Ochoa F., and Almagro J.C. Canonical structure repertoire of the antigen-binding site of immunoglobulins suggests strong geometrical restrictions associated to the mechanism of immune recognition. J. Mol. Biol. 254 (1995) 497-504
29. Harris S.L., Craig L., Mehroke J.S., Rashed M., Zwick M.B., Kenar K., et al. Exploring the basis of peptide-carbohydrate crossreactivity: evidence for discrimination by peptides between closely related anti-carbohydrate antibodies. Proc. Natl Acad. Sci. USA 94 (1997) 2454-2459
30. Kabsch W. Evaluation of single crystal X-ray diffraction data from a position-sensitive detector. J. Appl. Crystallogr. 21 (1988) 916-924
31. Collaborative Computing Project No. 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. Sect. D 50 (1994) 760-763
32. McCoy A.J., Grosse-Kunstleve R.W., Adams P.D., Winn M.D., Storoni L.C., and Read R.J. PHASER crystallographic software. J. Appl. Crystallogr. 40 (2007) 658-674
33. Pannu A.J., Murshudov G.N., Dodson E.J., and Read R.J. Incorporation of prior phase information strengthens maximum-likelihood structure refinement. Acta Crystallogr. Sect. D 54 (1998) 1285-1294
34. Perrakis A., Sixma T.K., Wilson K.S., and Lamzin V.S. wARP: improvement and extension of crystallographic phases by weighted averaging of multiple-refined dummy atomic models. Acta Crystallogr. Sect. D 53 (1997) 448-455
35. DeLano, W. L. (2002). The PyMOL molecular graphics system. http://www.pymol.org
36. Hwang T.L., and Shaka A.J. Water suppression that works. Excitation sculpting using arbitrary waveforms and pulsed field gradients. J. Magn. Res. 112 (1995) 275-279
37. Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., and Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6 (1995) 277-293
38. Johnson B.A., and Blevins R.A. NMRView-a computer-program for the visualization and analysis of NMR data. J. Biomol. NMR 4 (1994) 603-614
39. Mayer M., and Meyer B. Characterization of ligand binding by saturation transfer difference NMR spectroscopy. Angew. Chem. Int. Ed. 38 (1999) 1784-1788
40. 1ρ-filtered two-dimensional transferred NOE spectrum for studying antibody interactions with peptide antigens. Biophys. J. 64 (1993) 754-761
41. Linge J.P., O'Donoghue S.I., and Nilges M. Automated assignment of ambiguous nuclear Overhauser effects with ARIA. Nucl. Magn. Reson. Biol. Macromol. Part B 339 (2001) 71-90
42. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., et al. Crystallography and NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. Sect. D 54 (1998) 905-921
43. Vriend G. WHAT IF: a molecular modeling and drug design program. J. Mol. Graphics 8 (1990) 52-56
44. Schwarzinger S., Kroon G.J.A., Foss T.R., Wright P.E., and Dyson H.J. Random coil chemical shifts in acidic 8 M urea: implementation of random coil shift data in NMRView. J. Biomol. NMR 18 (2000) 43-48
45. Schwarzinger S., Kroon G.J.A., Foss T.R., Chung J., Wright P.E., and Dyson H.J. Sequence-dependent correction of random coil NMR chemical shifts. J. Am. Chem. Soc. 123 (2001) 2970-2978
46. 15N random coil NMR chemical shifts of the common amino acids: I. Investigations of nearest-neighbor effects. J. Biomol. NMR 5 (1995) 67-81